Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation [Phase 2]
Phase 2 clinical trial update for Belumosudil to address interstitial fibrosis and tubular atrophy following kidney transplantation, in the …
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR [Phase 4]
Phase 4 trial evaluating a simplified, low-dose tacrolimus (Envarsus XR) immunosuppressive protocol in kidney transplantation; the study sta…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: CMVIG Prophylaxis in Belatacept Conversion Kidney Transplant Recipients [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating cytomegalovirus immune globulin (CMVIG) prophylaxis in belatacept-converted kidney transplant recip…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Antibiotics for Kidney Transplant Recipients [Phase 4]
This Phase 4 clinical trial update covers antibiotics to prevent urinary tract infections in kidney transplant recipients, and the study is …
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients [Phase 1]
A Phase 1 clinical trial evaluating adipose-derived mesenchymal stem cells to treat rejection in kidney transplant recipients is currently r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Abatacept Conversion in Kidney Transplantation [Phase 2]
Emory University reports an ongoing Phase 2 clinical trial evaluating abatacept conversion in kidney transplant recipients. The study status…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: "A Privacy-protecting Environment for Child Transplants Health Related and Genomic Data Integration in the European Reference Network"
This update describes a research project to create a privacy-protecting data environment for pediatric transplant health data and genomic in…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
This clinical trial aims to detect plasma DNA of renal origin in kidney transplant patients and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic [Phase 4]
Phase 4 trial update on pharmacogenetic-guided tacrolimus dosing for kidney transplant patients; the study has completed.
-
EMA approval · 2025-09-17EMA Authorised: Rapamune (sirolimus) — Pfizer Europe MA EEIG
The EMA authorised Rapamune (sirolimus) for preventing graft rejection in kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies [Phase 4]
A Phase 4 clinical trial update indicates a study evaluating desmopressin to prevent bleeding during allograft kidney biopsies, with enrollm…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus [Phase 4]
Phase 4 trial evaluating whether pre-emptive genotyping to guide tacrolimus dosing improves effectiveness and cost-effectiveness in kidney t…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Effects of Empagliflozin in Reducing Oxidative Stress After Kidney Transplantation [NA]
A completed clinical trial evaluated whether empagliflozin reduces oxidative stress in kidney transplant recipients. The study was conducted…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: 1 vs 7 RATG Infusions in Renal Transplantation
This clinical trial update describes a study comparing 1 versus 7 infusions of rabbit anti-thymocyte globulin (RATG) in kidney transplant re…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: To Explore the Application Value of Magnetic Resonance Imaging in Noninvasive Quantitative Evaluation of Graft Function and Systemic Metabolism After Renal Transplantation
A clinical trial update investigating the use of magnetic resonance imaging to noninvasively quantify graft function and systemic metabolism…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients [Phase 4]
This update describes an ongoing Phase 4 trial evaluating the safety and efficacy of SGLT2 inhibitors on kidney allograft function in non-di…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Early Pharmacological and Immune Monitoring After Conversion to Belatacept in Renal Transplant Patients
This clinical trial update reports early pharmacological and immune monitoring data after converting kidney transplant recipients to belatac…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Exercise and Prediabetes After Renal Transplantation [NA]
This clinical trial update from University of La Laguna describes an exercise intervention to address prediabetes in individuals after kidne…
-
CLINICAL_TRIALS trial_result · 2025-08-01Clinical Trial Update: Continuous Glucose Monitoring (CGM) in Kidney-Transplanted Adults [NA]
ClinicalTrials.gov reports a terminated study evaluating continuous glucose monitoring in adults with diabetes and kidney transplantation, w…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: MR-proADM as a Early Biomarker for DGF and AR in Kidney and Liver Transplantation
A clinical trial from the University of Rome Tor Vergata is evaluating MR-proADM as an early biomarker for delayed graft function and acute …
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension [Phase 4]
A Phase 4 trial evaluating the acute effects of an SGLT2 inhibitor on kidney allograft oxygen tension in non-diabetic kidney transplant reci…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation [Phase 4]
Phase 4 pharmacokinetic study of tacrolimus (Adoport) in de novo kidney transplant recipients has completed.
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Use of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression [NA]
A clinical trial update on using DNA testing and gene expression profiling to help transition kidney transplant recipients to belatacept-onl…
-
EMA approval · 2025-07-02EMA Authorised: Idefirix (imlifidase) — Hansa Biopharma AB
The EMA authorised Idefirix (imlifidase) from Hansa Biopharma AB for desensitization to enable kidney transplantation in highly sensitised p…
-
FDA approval · 2025-06-27FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)
FDA approves a supplemental application for CellCept (mycophenolate mofetil hydrochloride) from Genentech, confirming an approved modificati…